LUMOSA THERAPEUTICS CO (ROCO:6535) Total Liabilities : NT$200.81 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is LUMOSA THERAPEUTICS CO Total Liabilities?

LUMOSA THERAPEUTICS CO's Total Liabilities for the quarter that ended in Mar. 2024 was NT$200.81 Mil.

LUMOSA THERAPEUTICS CO's quarterly Total Liabilities increased from Sep. 2023 (NT$190.83 Mil) to Dec. 2023 (NT$227.69 Mil) but then declined from Dec. 2023 (NT$227.69 Mil) to Mar. 2024 (NT$200.81 Mil).

LUMOSA THERAPEUTICS CO's annual Total Liabilities declined from Dec. 2021 (NT$230.11 Mil) to Dec. 2022 (NT$215.72 Mil) but then increased from Dec. 2022 (NT$215.72 Mil) to Dec. 2023 (NT$227.69 Mil).

LUMOSA THERAPEUTICS CO Total Liabilities Historical Data

The historical data trend for LUMOSA THERAPEUTICS CO's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LUMOSA THERAPEUTICS CO Total Liabilities Chart

LUMOSA THERAPEUTICS CO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

278.44

201.63

230.11

215.72

227.69

LUMOSA THERAPEUTICS CO Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															192.40	193.66	190.83	227.69	200.81

LUMOSA THERAPEUTICS CO Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

LUMOSA THERAPEUTICS CO's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	219.577	+	(8.117	+	-1.0658141036402E-14
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	227.69

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1656.279	-	1428.585
	=	227.69

LUMOSA THERAPEUTICS CO's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	193.372	+	(7.436	+	-2.1316282072803E-14
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	200.81

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1519.945	-	1319.137
	=	200.81

LUMOSA THERAPEUTICS CO Total Liabilities Related Terms

Thank you for viewing the detailed overview of LUMOSA THERAPEUTICS CO's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

LUMOSA THERAPEUTICS CO (ROCO:6535) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LUMOSA THERAPEUTICS CO LTD (ROCO:6535) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuanyuan Street, 4th Floor, No. 3-2, Nangang District, Taipei, TWN, 11503

Website

https://www.lumosa.com.tw

LUMOSA THERAPEUTICS CO LTD develops new drugs. The company is engaged in the development of drugs for unmet medical needs in the fields of CNS, oncology, and inflammatory diseases. Geographically, it derives a majority of its revenue from Asia and also has a presence in Taiwan and America. Its product portfolio includes LT - 1001 and LT - 3001 for Analgesic Injection and Novel Small Molecules for the Treatment of Acute Ischemic Stroke.

LUMOSA THERAPEUTICS CO (ROCO:6535) Headlines

No Headlines